All information on this site concerning The Brinson Funds is directed only towards United States citizens. Inc. The Fund seeks to provide long-term capital appreciation. The Fund employs a specialized sector strategy, and is anon-diversified portfolio. Stock selection is based on bottom-up, fundamental analysis.
Biotechnology companies generate value by developing new kinds of drugs and technologies.
The basis of the fundamental analysis is to analyze the science behind the drugs and technologies. Shares are not insured by the FDIC, Federal Reserve Board, or any other agency, and are subject to investment risks, including possible loss of principal amount invested. Please read the prospectus carefully before you invest or send money as it explains the risks associated with investing in international markets, including risks related to social and political instability, market illiquidity and currency volatility. Products and services in these pages may not be available for residents of certain nations. Please consult the sales restrictions relating to the service in question for further information.